All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - Ting
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response
Read more...
Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study
Read more...
Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
Read more...
Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
Read more...
Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis
Read more...
Antiplatelet Therapy in Flow Diversion
Read more...
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping
Read more...
Treatment of Bilateral Giant Fusiform Petrocavernous Aneurysms
Read more...
Initial experience with the novel p64MW HPC flow diverter from a cohort study in unruptured anterior circulation aneurysms under dual antiplatelet medication
Read more...
Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
Read more...
Risk Factor Analysis of Delayed Intracerebral Hemorrhage After Coil Embolization of Unruptured Cerebral Aneurysms
Read more...
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016
Read more...
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collabo
Read more...
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Read more...
Percutaneous Coronary Intervention With an Initial Bolus of Low-Dose Heparin in Biomarker-Negative Patients
Read more...
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Read more...
STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass
Read more...
2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery
Read more...
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Read more...
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage
Read more...
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration
Read more...
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial
Read more...
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery
Read more...
Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention
Read more...
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Read more...
Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis
Read more...
Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass
Read more...
How do we manage cardiopulmonary bypass coagulopathy?
Read more...
Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery
Read more...
Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study
Read more...
Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Read more...
Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery
Read more...
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Read more...
Platelet Reactivity Unit in Predicting Risk of Bleeding in Patients Undergoing Coronary Artery Bypass Graft Surgery
Read more...
Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow
Read more...
Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement
Read more...
Monitoring platelet reactivity during prasugrel or ticagrelor washout before urgent coronary artery bypass grafting
Read more...
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
Read more...
The absorption of aspirin is reduced after coronary artery bypass grafting
Read more...
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?
Read more...
Evaluating the effectiveness of pre-operative platelet inhibition testing to reduce costs and pre-operative length of stay
Read more...
Antiplatelet Therapy Bridging With Cangrelor in Patients With Coronary Stents: A Case Series
Read more...
Weight as an assay-independent predictor of poor response to enteric aspirin in cardiovascular patients
Read more...
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Read more...
Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series
Read more...
Platelet Activity Measured by VerifyNow® Aspirin Sensitivity Test Identifies Coronary Artery Bypass Surgery Patients at Increased Risk for Postoperative Bleeding and Transfusion
Read more...
Assessment of platelet function after discontinuation of ticagrelor
Read more...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
Read more...
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Read more...
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Read more...
Evening aspirin intake results in higher levels of platelet inhibition and a reduction in reticulated platelets - a window of opportunity for patients with cardiovascular disease?
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
Read more...
Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
Read more...
Open-label multicenter registry on the outcomes of peripheral arterial disease treated by balloon angioplasty with optical frequency domain imaging in superficial femoral artery and popliteal artery (OCEAN-SFA study)
Read more...
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention
Read more...
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
Read more...
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
D-dimer Triage for COVID-19
Read more...
Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
Read more...
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?
Read more...
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Read more...
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Read more...
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation
Read more...
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
Read more...
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring
Read more...
Macrothrombosis and stroke in patients with mild Covid‐19 infection
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Read more...
Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female
Read more...
Start
Prev
1
2
3
4
Next
End
Page 2 of 4
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection